The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.
Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.
Parent entities and officers
Active
4
- 1
Anderson, Barry Douglas
Director born in May 1958Individual (1 offspring)Officer
2014-02-28 ~ nowOF - Director → CIF 0Mr Barry Douglas Anderson
Born in May 1958Individual (1 offspring)Person with significant control 2020-01-01 ~ nowPE - Has significant influence or control → CIF 0 - 2
Valnoski, Margaret Jane
Company Director born in March 1956Individual (1 offspring)Officer 1994-02-01 ~ nowOF - Director → CIF 0Ms Margaret Jane Valnoski
Born in March 1956Individual (1 offspring)Person with significant control 2016-04-06 ~ nowPE - Has significant influence or control → CIF 0 - 3
Sullivan, Robin Jeffrey
Individual (1 offspring)Officer 2019-03-19 ~ nowOF - Secretary → CIF 0 - 4
Rosen, Hans Edvard
Managing Director born in May 1960Individual (1 offspring)Officer 2019-07-01 ~ nowOF - Director → CIF 0
Ceased
13
- 1
Royds, Robert Bruce, Dr
Company Director born in October 1944IndividualOfficer 1992-04-21 ~ 2013-03-23OF - Director → CIF 0 - 2
Saunders, Andrew
Medical Director born in February 1965Individual (1 offspring)Officer 1999-04-06 ~ 2000-07-20OF - Director → CIF 0 - 3
Moores, Marie Ester
Regulatory Affairs born in April 1968Individual (1 offspring)Officer 2001-08-01 ~ 2019-02-28OF - Director → CIF 0 - 4
Stewart, John Charles Marshall
Pharmaceutical Physician born in November 1943IndividualOfficer 2003-01-01 ~ 2010-04-08OF - Director → CIF 0 - 5
Adley, Jeffery David
Company Director born in March 1945IndividualOfficer 1999-04-06 ~ 2013-09-30OF - Director → CIF 0Adley, Jeffery David
IndividualOfficer 2005-12-06 ~ 2013-09-30OF - Secretary → CIF 0 - 6
Neagle, Glynis Mary, Dr
Medical Director born in May 1965Individual (1 offspring)Officer 2000-07-20 ~ 2001-12-31OF - Director → CIF 0 - 7
Malins, Deborah Russell
Head Of Quality Assurance born in April 1955Individual (1 offspring)Officer 2005-10-01 ~ 2006-06-30OF - Director → CIF 0 - 8
Hannan, John Stephen
Director born in June 1960Individual (2 offsprings)Officer 2013-09-16 ~ 2018-12-31OF - Director → CIF 0Hannan, John Stephen
Individual (2 offsprings)Officer 2013-09-30 ~ 2018-12-31OF - Secretary → CIF 0 - 9
Rohrbaugh, Thomas Morrison, Doctor
Company Director Proposed born in December 1951IndividualOfficer 1992-04-21 ~ 1994-01-31OF - Director → CIF 0 - 10
Lim, John Kin Chaun, Doctor
Managing Director born in April 1960IndividualOfficer 1993-12-02 ~ 1996-07-01OF - Director → CIF 0 - 11
Leonard, Bruce Edward
Company Director born in April 1954IndividualOfficer 1992-04-21 ~ 2005-12-06OF - Director → CIF 0Leonard, Bruce Edward
Company Director ProposedIndividualOfficer 1992-04-21 ~ 2005-12-06OF - Secretary → CIF 0 - 12MCB NOMINEES LIMITED
Classic House, 174-180 Old Street, LondonDissolved Corporate (1 parent, 1 offspring)Equity (Company account)1 GBP2019-11-30Officer1992-04-21 ~ 1992-04-21PE - Nominee Director → CIF 0 - 13Classic House, 174-180 Old Street, LondonCorporate (2 offsprings)Officer1992-04-21 ~ 1992-04-21PE - Nominee Secretary → CIF 0
Company in focus
THERADEX (EUROPE) LIMITED
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Par Value of Share
Class 1 ordinary share
12023-07-01 ~ 2024-06-30
Turnover/Revenue
12,147,686 GBP2023-07-01 ~ 2024-06-30
10,845,152 GBP2022-07-01 ~ 2023-06-30
Cost of Sales
6,713,841 GBP2023-07-01 ~ 2024-06-30
5,662,319 GBP2022-07-01 ~ 2023-06-30
Gross Profit/Loss
5,433,845 GBP2023-07-01 ~ 2024-06-30
5,182,833 GBP2022-07-01 ~ 2023-06-30
Administrative Expenses
3,707,493 GBP2023-07-01 ~ 2024-06-30
3,816,503 GBP2022-07-01 ~ 2023-06-30
Operating Profit/Loss
1,949,834 GBP2023-07-01 ~ 2024-06-30
1,366,330 GBP2022-07-01 ~ 2023-06-30
Other Interest Receivable/Similar Income (Finance Income)
51,472 GBP2023-07-01 ~ 2024-06-30
8,812 GBP2022-07-01 ~ 2023-06-30
Profit/Loss on Ordinary Activities Before Tax
2,001,306 GBP2023-07-01 ~ 2024-06-30
1,375,142 GBP2022-07-01 ~ 2023-06-30
Tax/Tax Credit on Profit or Loss on Ordinary Activities
145,298 GBP2023-07-01 ~ 2024-06-30
279,679 GBP2022-07-01 ~ 2023-06-30
Profit/Loss
1,856,008 GBP2023-07-01 ~ 2024-06-30
1,095,463 GBP2022-07-01 ~ 2023-06-30
Comprehensive Income/Expense
1,856,008 GBP2023-07-01 ~ 2024-06-30
1,095,463 GBP2022-07-01 ~ 2023-06-30
Property, Plant & Equipment
30,157 GBP2024-06-30
50,565 GBP2023-06-30
Debtors
3,208,199 GBP2024-06-30
2,616,661 GBP2023-06-30
Cash at bank and in hand
11,671,371 GBP2024-06-30
8,605,192 GBP2023-06-30
Current Assets
14,879,570 GBP2024-06-30
11,221,853 GBP2023-06-30
Creditors
Current
5,233,660 GBP2024-06-30
3,444,429 GBP2023-06-30
Net Current Assets/Liabilities
9,645,910 GBP2024-06-30
7,777,424 GBP2023-06-30
Total Assets Less Current Liabilities
9,676,067 GBP2024-06-30
7,827,989 GBP2023-06-30
Creditors
Non-current
-3,028 GBP2023-06-30
Net Assets/Liabilities
9,669,441 GBP2024-06-30
7,813,433 GBP2023-06-30
Equity
Called up share capital
100 GBP2024-06-30
100 GBP2023-06-30
100 GBP2022-06-30
Retained earnings (accumulated losses)
9,669,341 GBP2024-06-30
7,813,333 GBP2023-06-30
6,717,870 GBP2022-06-30
Equity
9,669,441 GBP2024-06-30
7,813,433 GBP2023-06-30
6,717,970 GBP2022-06-30
Comprehensive Income/Expense
Retained earnings (accumulated losses)
1,856,008 GBP2023-07-01 ~ 2024-06-30
1,095,463 GBP2022-07-01 ~ 2023-06-30
Wages/Salaries
6,337,437 GBP2023-07-01 ~ 2024-06-30
5,511,198 GBP2022-07-01 ~ 2023-06-30
Social Security Costs
483,527 GBP2023-07-01 ~ 2024-06-30
266,247 GBP2022-07-01 ~ 2023-06-30
Pension & Other Post-employment Benefit Costs/Other Pension Costs
273,926 GBP2023-07-01 ~ 2024-06-30
214,378 GBP2022-07-01 ~ 2023-06-30
Staff Costs/Employee Benefits Expense
7,094,890 GBP2023-07-01 ~ 2024-06-30
5,991,823 GBP2022-07-01 ~ 2023-06-30
Average Number of Employees
382023-07-01 ~ 2024-06-30
422022-07-01 ~ 2023-06-30
Director Remuneration
277,042 GBP2023-07-01 ~ 2024-06-30
258,380 GBP2022-07-01 ~ 2023-06-30
Property, Plant & Equipment - Depreciation Expense
Owned assets
30,234 GBP2023-07-01 ~ 2024-06-30
41,020 GBP2022-07-01 ~ 2023-06-30
Audit Fees/Expenses
38,350 GBP2023-07-01 ~ 2024-06-30
33,770 GBP2022-07-01 ~ 2023-06-30
Current Tax for the Period
312,078 GBP2023-07-01 ~ 2024-06-30
269,577 GBP2022-07-01 ~ 2023-06-30
Tax Expense/Credit at Applicable Tax Rate
500,327 GBP2023-07-01 ~ 2024-06-30
261,277 GBP2022-07-01 ~ 2023-06-30
Property, Plant & Equipment - Gross Cost
Plant and equipment
266,384 GBP2024-06-30
272,561 GBP2023-06-30
Property, Plant & Equipment - Disposals
Plant and equipment
-16,240 GBP2023-07-01 ~ 2024-06-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
236,227 GBP2024-06-30
221,996 GBP2023-06-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
30,234 GBP2023-07-01 ~ 2024-06-30
Property, Plant & Equipment - Decrease in depreciation and impairment related to disposals
Plant and equipment
-16,003 GBP2023-07-01 ~ 2024-06-30
Property, Plant & Equipment
Plant and equipment
30,157 GBP2024-06-30
50,565 GBP2023-06-30
Trade Debtors/Trade Receivables
Current
2,061,956 GBP2024-06-30
2,264,315 GBP2023-06-30
Other Debtors
Current
241,331 GBP2024-06-30
40,903 GBP2023-06-30
Amount of corporation tax that is recoverable
Current
136,163 GBP2024-06-30
Prepayments/Accrued Income
Current
190,113 GBP2024-06-30
176,526 GBP2023-06-30
Debtors
Amounts falling due within one year, Current
3,208,199 GBP2024-06-30
2,616,661 GBP2023-06-30
Trade Creditors/Trade Payables
Current
273,323 GBP2024-06-30
360,747 GBP2023-06-30
Amounts owed to group undertakings
Current
1,352,489 GBP2024-06-30
888,251 GBP2023-06-30
Corporation Tax Payable
Current
220,063 GBP2023-06-30
Other Taxation & Social Security Payable
Current
83,074 GBP2024-06-30
96,504 GBP2023-06-30
Other Creditors
Current
62,472 GBP2024-06-30
93,666 GBP2023-06-30
Accrued Liabilities/Deferred Income
Current
3,298,360 GBP2024-06-30
1,751,427 GBP2023-06-30
Other Creditors
Non-current
3,028 GBP2023-06-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
123,930 GBP2024-06-30
131,994 GBP2023-06-30
Between one and five year
393,900 GBP2024-06-30
480,744 GBP2023-06-30
More than five year
39,390 GBP2023-06-30
All periods
517,830 GBP2024-06-30
652,128 GBP2023-06-30
Amounts set aside to cover potential liabilities or losses
Deferred taxation
6,626 GBP2024-06-30
11,528 GBP2023-06-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
100 shares2024-06-30
Profit/Loss
Retained earnings (accumulated losses)
1,856,008 GBP2023-07-01 ~ 2024-06-30
- Registered number 02708052
THERADEX (EUROPE) LIMITED
InfoChancery House, 3 Hatchlands Road, Redhill, Surrey RH1 6AAPrivate Limited Company incorporated on 1992-04-21 (33 years 5 months). The company status is Active.The last date of confirmation statement was made at 2025-04-21CIF 0
Offspring entities and appointments
Active
0
- Not found in our database.
The content of this website is protected by AgonGuard.
© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.
Contains public sector information retrieved at 24 April 2025 and
licensed under the Open Government Licence v3.0.